A proprietary platform to fight cancer: a technology transfer case study

episode

Talk innovation: unlocking technology not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from Talk innovation: unlocking technology

Battery circularity: how used EV batteries become future resources 15 min · 03 Jul 2026

Out of the Box: how smart lighting saves lives 15 min · 23 Jun 2026

Luca Rossettini's mission to clean up space debris 38 min · 09 Jun 2026

All episodes from Talk innovation: unlocking technology →

Report any issue

Source

Recorded11 May 2023

Publisheranchor.fm ↗

Handlerec:13131476

Show notes

Two scientists-turned-entrepreneurs have created the technology platform S-TIR for immunology vaccines, enabling treatments for allergies and cancer. Based on their strong patent portfolio they founded several start-up companies for product development and technology commercialisation. In this podcast they explain how IP was essential for attracting investment as well as generating licensing revenue early on. This was crucial given the long time-to-market periods that are typical in biotechnology. The EPO has recently published three new case studies highlighting the role of IP in creating businesses that are bringing technologies to market to diagnose and/or treat cancer. Download the case studies: https://www.epo.org/learning/materials/sme/innovation-case-studies/technology-transfer-case-studies.html

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.